Jonathan Coy
Overview
Explore the profile of Jonathan Coy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
590
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cronise K, Coy J, Dow S, Hauck M, Regan D
Vet Comp Oncol
. 2024 May;
22(3):377-387.
PMID: 38752589
Immune checkpoint inhibitor therapy can provide significant clinical benefit in patients with certain cancer types including melanoma; however, objective responses are only observed for a subset of patients. Mucosal melanoma...
2.
Alfino L, Wilczewski-Shirai K, Cronise K, Coy J, Glapa K, Ehrhart E, et al.
Vet Pathol
. 2021 Mar;
58(5):981-993.
PMID: 33685296
Periostin is a matricellular protein important in regulating bone, tooth, and cardiac development. In pathologic conditions, periostin drives allergic and fibrotic inflammatory diseases and is also overexpressed in certain cancers....
3.
Chow L, Johnson V, Impastato R, Coy J, Strumpf A, Dow S
Stem Cells Transl Med
. 2019 Nov;
9(2):235-249.
PMID: 31702119
Mesenchymal stem cells (MSC) have been shown to improve wound healing and suppress inflammatory immune responses. Newer research also indicates that MSC exhibit antimicrobial activity, although the mechanisms underlying this...
4.
Soontararak S, Chow L, Johnson V, Coy J, Webb C, Wennogle S, et al.
PLoS One
. 2019 Aug;
14(8):e0220522.
PMID: 31369623
Inflammatory bowel disease (IBD) in dogs is associated with clinical signs of intestinal dysfunction, as well as abnormal lymphocytic and myeloid cell infiltrates in the small and/or large intestine. Thus,...
5.
Wheat W, Chow L, Coy J, Contreras E, Lappin M, Dow S
J Vet Intern Med
. 2019 Feb;
33(2):838-845.
PMID: 30770582
Background: Nonspecific induction of local innate immune responses by mucosally administered immunotherapy is a new approach to protection from upper respiratory tract infections. Therefore, a new liposome-toll-like receptor complex (LTC)...
6.
Soontararak S, Chow L, Johnson V, Coy J, Wheat W, Regan D, et al.
Stem Cells Transl Med
. 2018 Apr;
7(6):456-467.
PMID: 29635868
Cellular therapy with allogeneic or autologous mesenchymal stem cells (MSC) has emerged as a promising new therapeutic strategy for managing inflammatory bowel disease (IBD). However, MSC therapy ideally requires a...
7.
Johnson V, Webb T, Norman A, Coy J, Kurihara J, Regan D, et al.
Sci Rep
. 2017 Aug;
7(1):9575.
PMID: 28851894
Chronic bacterial infections associated with biofilm formation are often difficult to resolve without extended courses of antibiotic therapy. Mesenchymal stem cells (MSC) exert antibacterial activity in vitro and in acute...
8.
Chow L, Johnson V, Coy J, Regan D, Dow S
Stem Cells Dev
. 2016 Nov;
26(5):374-389.
PMID: 27881051
Mesenchymal stem cells (MSCs) from rodents and humans have been shown to suppress T cells by distinct primary pathways, with nitric oxide (NO)-dependent pathways dominating in rodents and indoleamine 2,3-deoxygenase...
9.
Cherry A, Haas B, Naydenov A, Fung S, Xu C, Swinney K, et al.
Mol Cancer Ther
. 2016 Jun;
15(9):2018-29.
PMID: 27325686
Glioblastoma multiforme is a devastating and intractable type of cancer. Current antineoplastic drugs do not improve the median survival of patients diagnosed with glioblastoma multiforme beyond 14 to 15 months,...
10.
Regan D, Guth A, Coy J, Dow S
Vet J
. 2015 Nov;
207:20-28.
PMID: 26545847
Excitement in the field of tumor immunotherapy is being driven by several remarkable breakthroughs in recent years. This review will cover recent advances in cancer immunotherapy, including the use of...